Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04908956
Title Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Thoracic Oncology Platform

lung non-small cell carcinoma



Age Groups: adult | senior
Covered Countries ITA | ESP

No variant requirements are available.